Skeletal muscle is an abundant tissue in the human body that can be functionally compromised due to trauma or a range of genetic, metabolic and neuromuscular diseases. Functional human skeletal muscle progenitor cells (myoblasts) can be derived from human induced pluripotent stem cells (hiPSC). This project will establish a high-content cell phenotyping platform combining morphological, cell marker staining and activation of cell signaling pathways to compare the phenotype of hiPSC-derived myoblasts with myoblasts isolated from donor skeletal muscle. The project will generate valuable new information regarding use of hiPSC-derived myoblasts for disease modelling, testing new therapeutics and developing regenerative medicines.
(1) van der Wal et al. Large-Scale Expansion of Human iPSC-Derived Skeletal Muscle Cells for Disease Modeling and Cell-Based Therapeutic Strategies. Stem Cell Reports. 2018;10:1975-1990. doi: 10.1016/j.stemcr.2018.04.002
(2) Wiseman et al. Integrated Multiparametric High-Content Profiling of Endothelial Cells. SLAS Discov. 2019;24:264-273. doi: 10.1177/2472555218820848.
(3) Leha et al. A high-content platform to characterise human induced pluripotent stem cell lines. Methods. 2016;96:85-96. doi: 10.1016/j.ymeth.2015.11.012.
(4) Parmar, N., Day, R.M. (2015) TIPS to manipulate myogenesis: retention of myoblast differentiation capacity using microsphere culture. Eur Cell Mater. 30:41-50. doi:10.1155/2014/713631